Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

BACKGROUND: Hyperferritinemic syndromes are systemic inflammatory disorders characterized by a dysfunctional immune response, which leads to excessive activation of the monocyte-macrophage system with hypercytokinemia and may pursue a rapidly fatal course. CASE PRESENTATION: We describe two patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Papa, Riccardo, Natoli, Valentina, Caorsi, Roberta, Minoia, Francesca, Gattorno, Marco, Ravelli, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353681/
https://www.ncbi.nlm.nih.gov/pubmed/32653009
http://dx.doi.org/10.1186/s12969-020-00450-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353681/
https://www.ncbi.nlm.nih.gov/pubmed/32653009
http://dx.doi.org/10.1186/s12969-020-00450-9

Ejemplares similares